Sandoz Group AG (SDZ) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.114x

Based on the latest financial reports, Sandoz Group AG (SDZ) has a cash flow conversion efficiency ratio of 0.114x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF1.07 Billion ≈ $1.35 Billion USD) by net assets (CHF9.38 Billion ≈ $11.87 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See SDZ days of operational coverage to measure how many days the company can operate on defensive assets alone.

Sandoz Group AG - Cash Flow Conversion Efficiency Trend (2020–2025)

This chart illustrates how Sandoz Group AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Sandoz Group AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sandoz Group AG ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Nokia Oyj
HE:NOKIA
0.030x
Vodafone Group Plc
F:VODJ
0.104x
Nestle India Limited
NSE:NESTLEIND
0.522x
Kellanova
NYSE:K
0.117x
Muyuan Foodstuff Co Ltd
SHE:002714
0.015x
Raymond James Financial Inc.
NYSE:RJF
0.011x
Grupo Financiero Banorte S.A.B. de C.V
MX:GFNORTEO
0.124x
China State Construction Engineering Corp Ltd
SHG:601668
0.033x

Annual Cash Flow Conversion Efficiency for Sandoz Group AG (2020–2025)

The table below shows the annual cash flow conversion efficiency of Sandoz Group AG from 2020 to 2025. For the full company profile with market capitalisation and key ratios, see Sandoz Group AG market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CHF9.38 Billion
≈ $11.87 Billion
CHF1.59 Billion
≈ $2.02 Billion
0.170x +111.37%
2024-12-31 CHF8.16 Billion
≈ $10.32 Billion
CHF656.00 Million
≈ $829.36 Million
0.080x +113.76%
2023-12-31 CHF8.65 Billion
≈ $10.94 Billion
CHF325.31 Million
≈ $411.28 Million
0.038x -100.00%
2022-12-31 CHF77.14K
≈ $97.52K
CHF1.17 Billion
≈ $1.48 Billion
15142.076x +9097643.39%
2021-12-31 CHF7.44 Billion
≈ $9.40 Billion
CHF1.24 Billion
≈ $1.57 Billion
0.166x +10.25%
2020-12-31 CHF6.83 Billion
≈ $8.63 Billion
CHF1.03 Billion
≈ $1.30 Billion
0.151x --

About Sandoz Group AG

SW:SDZ Switzerland Drug Manufacturers - Specialty & Generic
Market Cap
$34.41 Billion
CHF27.22 Billion CHF
Market Cap Rank
#910 Global
#16 in Switzerland
Share Price
CHF62.90
Change (1 day)
+0.00%
52-Week Range
CHF42.30 - CHF72.42
All Time High
CHF72.42
About

Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of ac… Read more